Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
作者： José Baselga , Sandra M. Swain
DOI: 10.1038/NRC2656
关键词: Receptor 、 Epidermal growth factor receptor 、 Monoclonal 、 ERBB3 、 ErbB 、 Cell biology 、 Receptor expression 、 Cancer 、 Biology 、 Tyrosine kinase 、 Cancer research 、 Oncology
摘要: Aberrant receptor expression or functioning of the epidermal growth factor receptor (Erbb) family plays a crucial part in the development and evolution of cancer. Inhibiting the signalling …
nature.com
uninsubria.it 参考文章(142)
Chia C. Portera, Janice M. Walshe, Douglas R. Rosing, Neelima Denduluri, Arlene W. Berman, Ujala Vatas, Margarita Velarde, Catherine K. Chow, Seth M. Steinberg, Diana Nguyen, Sherry X. Yang, Sandra M. Swain, Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer. Clinical Cancer Research. ,vol. 14, pp. 2710- 2716 ,(2008) , 10.1158/1078-0432.CCR-07-4636
Antonino Musolino, Nadia Naldi, Beatrice Bortesi, Debora Pezzuolo, Marzia Capelletti, Gabriele Missale, Diletta Laccabue, Alessandro Zerbini, Roberta Camisa, Giancarlo Bisagni, Tauro Maria Neri, Andrea Ardizzoni, Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer Journal of Clinical Oncology. ,vol. 26, pp. 1789- 1796 ,(2008) , 10.1200/JCO.2007.14.8957
M. A. Olayioye, The ErbB signaling network: receptor heterodimerization in development and cancer The EMBO Journal. ,vol. 19, pp. 3159- 3167 ,(2000) , 10.1093/EMBOJ/19.13.3159
C.M. QUINN, J.L. OSTROWSKI, S.A. LANE, D.P. LONEY, J. TEASDALE, E.A. BENSON, c-erbB-3 protein expression in human breast cancer : comparison with other tumour variables and survival Histopathology. ,vol. 25, pp. 247- 252 ,(1994) , 10.1111/J.1365-2559.1994.TB01324.X
Raphael A. Clynes, Terri L. Towers, Leonard G. Presta, Jeffrey V. Ravetch, Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets Nature Medicine. ,vol. 6, pp. 443- 446 ,(2000) , 10.1038/74704
A. Negro, B. K. Brar, Y. Gu, K. L. Peterson, W. Vale, K.-F. Lee, erbB2 is required for G protein-coupled receptor signaling in the heart Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 15889- 15893 ,(2006) , 10.1073/PNAS.0607499103
Rita Nahta, Mien-Chie Hung, Francisco J. Esteva, The HER-2-Targeting Antibodies Trastuzumab and Pertuzumab Synergistically Inhibit the Survival of Breast Cancer Cells Cancer Research. ,vol. 64, pp. 2343- 2346 ,(2004) , 10.1158/0008-5472.CAN-03-3856
Si Tuen Lee-Hoeflich, Lisa Crocker, Evelyn Yao, Thinh Pham, Xander Munroe, Klaus P. Hoeflich, Mark X. Sliwkowski, Howard M. Stern, A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy Cancer Research. ,vol. 68, pp. 5878- 5887 ,(2008) , 10.1158/0008-5472.CAN-08-0380
Cary D. Austin, Ann M. De Mazière, Paul I. Pisacane, Suzanne M. van Dijk, Charles Eigenbrot, Mark X. Sliwkowski, Judith Klumperman, Richard H. Scheller, Endocytosis and Sorting of ErbB2 and the Site of Action of Cancer Therapeutics Trastuzumab and Geldanamycin Molecular Biology of the Cell. ,vol. 15, pp. 5268- 5282 ,(2004) , 10.1091/MBC.E04-07-0591
D. Slamon, G. Clark, S. Wong, W. Levin, A Ullrich, W. McGuire, Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science. ,vol. 235, pp. 177- 182 ,(1987) , 10.1126/SCIENCE.3798106